Ahmet Özdemir Selected Research

Thiazoles

1/2021	A New Series of Antileukemic Agents: Design, Synthesis, In Vitro and In Silico Evaluation of Thiazole-Based ABL1 Kinase Inhibitors.
11/2019	Design, synthesis and biological evaluation of a new series of thiazolyl-pyrazolines as dual EGFR and HER2 inhibitors.
5/2018	Design, Synthesis, and Evaluation of a New Series of Thiazole-Based Anticancer Agents as Potent Akt Inhibitors.
1/2016	Synthesis and evaluation of bis-thiazole derivatives as new anticancer agents.
3/2015	A novel series of thiazolyl-pyrazoline derivatives: synthesis and evaluation of antifungal activity, cytotoxicity and genotoxicity.
9/2014	Synthesis and in vitro evaluation of new nitro-substituted thiazolyl hydrazone derivatives as anticandidal and anticancer agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ahmet Özdemir Research Topics

Disease

11	Neoplasms (Cancer) 01/2021 - 12/2012
7	Adenocarcinoma of Lung 01/2022 - 01/2016
5	Glioma (Gliomas) 07/2018 - 01/2016
2	Sepsis (Septicemia) 09/2022 - 01/2015
2	Diabetes Complications 08/2021 - 01/2020
2	Adenocarcinoma 11/2019 - 01/2018
2	Pseudohypoaldosteronism 01/2019 - 06/2015
1	Hyperphosphatemia 11/2021
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 11/2021
1	Asphyxia (Suffocation) 11/2021
1	Hypocalcemia 11/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Cataract (Cataracts) 01/2020
1	Melanoma (Melanoma, Malignant) 11/2019
1	Necrotizing Enterocolitis 01/2019
1	Hypopituitarism (Sheehan's Syndrome) 01/2019
1	Pituitary Diseases (Disease, Anterior Pituitary) 01/2019
1	Parkinson Disease (Parkinson's Disease) 08/2018
1	Pheochromocytoma 08/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2018
1	Hemorrhage 06/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Necrosis 01/2018
1	Renal Insufficiency (Renal Failure) 01/2018
1	Metabolic Bone Diseases (Osteopenia) 01/2018
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2017
1	Thyrotoxicosis 03/2017
1	Epilepsy (Aura) 01/2017
1	Obesity 01/2017
1	Glaucoma 01/2017
1	Bronchiolitis 03/2016
1	Prostatic Neoplasms (Prostate Cancer) 01/2016
1	Hyponatremia 06/2015

Drug/Important Bio-Agent (IBA)

9	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 12/2012
6	ThiazolesIBA 01/2021 - 09/2014
3	Hormones (Hormone)IBA 01/2019 - 06/2015
2	AntioxidantsIBA 09/2022 - 01/2015
2	ElectrolytesIBA 11/2021 - 06/2015
2	Aldehyde Reductase (Aldose Reductase)IBA 08/2021 - 01/2020
2	ErbB Receptors (EGF Receptor)IBA 11/2020 - 11/2019
2	AldosteroneIBA 01/2019 - 06/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 12/2013
1	LipopolysaccharidesIBA 09/2022
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2022
1	CalciumIBA 11/2021
1	Phosphorus (Red Phosphorus)IBA 11/2021
1	Phosphates (Orthophosphate)IBA 11/2021
1	MagnesiumIBA 11/2021
1	compound 20IBA 08/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	HydrazonesIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2020
1	EnzymesIBA 11/2020
1	Sorbitol (Yal)FDA Link 01/2020
1	polyolIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	NADP (NADPH)IBA 01/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2019
1	GhrelinIBA 01/2019
1	Oxidopamine (6 Hydroxydopamine)IBA 08/2018
1	Free RadicalsIBA 08/2018
1	Neuroprotective AgentsIBA 08/2018
1	1,3,4-oxadiazoleIBA 07/2018
1	cupric sulfide (CuS)IBA 06/2018
1	Indicators and Reagents (Reagents)IBA 06/2018
1	IndansIBA 01/2018
1	AcetamidesIBA 01/2018
1	Cystatin CIBA 01/2018
1	1,3,4-thiadiazoleIBA 12/2017
1	Biological ProductsIBA 12/2017
1	bcr-abl Fusion ProteinsIBA 12/2017
1	OxadiazolesIBA 07/2017
1	Biomarkers (Surrogate Marker)IBA 07/2017
1	Matrix Metalloproteinases (MMPs)IBA 07/2017
1	Peptide Hydrolases (Proteases)FDA Link 07/2017
1	TriazolesIBA 07/2017
1	ThiadiazolesIBA 07/2017
1	Thyrotropin Receptors (Thyrotropin Receptor)IBA 03/2017
1	AntibodiesIBA 03/2017
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 01/2017
1	Indomethacin (Indometacin)FDA LinkGeneric 05/2016
1	Saline SolutionIBA 03/2016
1	BromidesIBA 01/2016
1	ThiosemicarbazonesIBA 01/2016
1	naphthaleneIBA 01/2016
1	SaltsIBA 06/2015
1	Cisplatin (Platino)FDA LinkGeneric 03/2015
1	furanIBA 09/2014
1	Caspase 3 (Caspase-3)IBA 12/2013

Therapy/Procedure

1	Induced Hypothermia 11/2021
1	Therapeutics 01/2021